September 28, 2015
BioDelivery Sciences International Inc. and two others dodged an infringement suit Friday related to the painkiller Onsolis, which is used to treat cancer patients, convincing a New Jersey federal judge that they're not liable for any infringement that occurred before two asserted patents were amended, under the intervening rights doctrine.